Dr. Girish Sahni is a pioneer in translating and helping others translate science into world-class applied technology in India. Dr. Sahni and his group at CSIR-Institute of Microbial Technology (IMTECH) have developed four generations of an important life-saver protein drug, streptokinase, that is used as ‘clot buster’ in many cardiac and circulatory diseases. He is the recipient of several accolades and awards, including the Ranbaxy award, CSIR Technology Shield, Department of Biotechnology Govt of India award for Process Development, Vigyan Ratan award of Panjab University etc. Dr Sahni is a Fellow of the Indian National Science Academy (INSA), India Academy of Science and the National Academy of Science (NASI).
Since 2015, Dr. Girish Sahni has held the position of Director General of the Council of Scientific Research (CSIR) and Secretary to the Government of India in the Department of Scientific and Industrial Research under the Ministry of Science and Technology. Prior to this, he was the Director of CSIR-Institute of Microbial Technology. He did his undergraduate and Masters from Panjab University, Chandigarh, and Ph. D. from the prestigious Indian Institute of Science, Bangalore.
Before joining IMTECH, and CSIR, in 1991, he pursued Postdoctoral Research in various prestigious Institutions in the USA including Univ. of California, Santa Barbara, CA; Albert Einstein College of Medicine, New York and the Rockefeller Univ., New York, USA, where he was also Adjunct Faculty.
Dr. Sahni is striving to refocus the Council of Scientific and Industrial Research, one of the world's top-10 publicly funded research Institutes by SCIMAGO, towards using first-grade scientific knowledge to provide technological and sustainable solutions to the various challenging problems facing the country and its Common Man.